de ProShare Advisors Vanda Pharmaceuticals VNDA Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Vender |
-10,731
| Cerradas | -USD 74.2 k | – | 2028 |
|
|
2026
Q1 | USD 74.2 k | Vender |
10,731
-2,058
| -16% | -USD 15.9 k | ﹤0.01% | 1746 |
|
|
2025
Q4 | USD 113 k | Comprar |
12,789
+1,158
| +10% | +USD 6.37 k | ﹤0.01% | 1851 |
|
|
2025
Q3 | USD 58 k | Vender |
11,631
-1,994
| -15% | -USD 9.23 k | ﹤0.01% | 1922 |
|
|
2025
Q2 | USD 64.3 k | Vender |
13,625
-1,345
| -9% | -USD 5.88 k | ﹤0.01% | 1960 |
|
|
2025
Q1 | USD 68.7 k | Vender |
14,970
-3,845
| -20% | -USD 17.9 k | ﹤0.01% | 1910 |
|
|
2024
Q4 | USD 90.1 k | Comprar |
18,815
+4,599
| +32% | +USD 22.1 k | ﹤0.01% | 2091 |
|
|
2024
Q3 | USD 66.7 k | Comprar |
14,216
+3,058
| +27% | +USD 16.4 k | ﹤0.01% | 1942 |
|
|
2024
Q2 | USD 63 k | Vender |
11,158
-3,022
| -21% | -USD 15.6 k | ﹤0.01% | 1719 |
|
|
2024
Q1 | USD 58.3 k | Comprar |
14,180
+1,154
| +9% | +USD 4.62 k | ﹤0.01% | 1888 |
|
|
2023
Q4 | USD 55 k | Comprar |
13,026
+1,928
| +17% | +USD 7.78 k | ﹤0.01% | 1849 |
|
|
2023
Q3 | USD 47.9 k | Vender |
11,098
-1,465
| -12% | -USD 8.14 k | ﹤0.01% | 1720 |
|
|
2023
Q2 | USD 82.8 k | Comprar |
12,563
+544
| +5% | +USD 3.49 k | ﹤0.01% | 1723 |
|
|
2023
Q1 | USD 81.6 k | Vender |
12,019
-1,413
| -11% | -USD 9.9 k | ﹤0.01% | 1623 |
|
|
2022
Q4 | USD 99.3 k | Comprar |
13,432
+1,014
| +8% | +USD 9.9 k | ﹤0.01% | 1652 |
|
|
2022
Q3 | USD 122 k | Comprar |
12,418
+163
| +1% | +USD 1.72 k | ﹤0.01% | 1516 |
|
|
2022
Q2 | USD 134 k | Vender |
12,255
-5,746
| -32% | -USD 59.5 k | ﹤0.01% | 1559 |
|
|
2022
Q1 | USD 203 k | Vender |
18,001
-3,557
| -16% | -USD 46.8 k | ﹤0.01% | 1880 |
|
|
2021
Q4 | USD 337 k | Comprar |
21,558
+1,214
| +6% | +USD 21.2 k | ﹤0.01% | 1718 |
|
|
2021
Q3 | USD 349 k | Vender |
20,344
-5,365
| -21% | -USD 94 k | ﹤0.01% | 1436 |
|
|
2021
Q2 | USD 553 k | Comprar |
25,709
+2,133
| +9% | +USD 38.2 k | ﹤0.01% | 1460 |
|
|
2021
Q1 | USD 354 k | Comprar |
23,576
+2,183
| +10% | +USD 35.3 k | ﹤0.01% | 1694 |
|
|
2020
Q4 | USD 281 k | Comprar |
21,393
+5,012
| +31% | +USD 60.3 k | ﹤0.01% | 1658 |
|
|
2020
Q3 | USD 158 k | Vender |
16,381
-547
| -3% | -USD 5.85 k | ﹤0.01% | 1458 |
|
|
2020
Q2 | USD 194 k | Comprar |
16,928
+5,671
| +50% | +USD 64.2 k | ﹤0.01% | 1469 |
|
|
2020
Q1 | USD 117 k | Vender |
11,257
-8,803
| -44% | -USD 109 k | ﹤0.01% | 1063 |
|
|
2019
Q4 | USD 329 k | Vender |
20,060
-1,618
| -7% | -USD 24.5 k | ﹤0.01% | 1282 |
|
|
2019
Q3 | USD 288 k | Vender |
21,678
-742
| -3% | -USD 10.3 k | ﹤0.01% | 1256 |
|
|
2019
Q2 | USD 316 k | Vender |
22,420
-2,561
| -10% | -USD 40.8 k | ﹤0.01% | 1214 |
|
|
2019
Q1 | USD 460 k | Comprar |
24,981
+321
| +1% | +USD 7.31 k | ﹤0.01% | 1045 |
|
|
2018
Q4 | USD 644 k | Vender |
24,660
-2,982
| -11% | -USD 70.1 k | ﹤0.01% | 861 |
|
|
2018
Q3 | USD 634 k | Vender |
27,642
-1,019
| -4% | -USD 20.8 k | ﹤0.01% | 1010 |
|
|
2018
Q2 | USD 546 k | Comprar |
28,661
+2,023
| +8% | +USD 33.8 k | ﹤0.01% | 1070 |
|
|
2018
Q1 | USD 449 k | Vender |
26,638
-4,106
| -13% | -USD 68.7 k | ﹤0.01% | 1144 |
|
|
2017
Q4 | USD 467 k | Comprar |
30,744
+2,453
| +9% | +USD 36.4 k | ﹤0.01% | 1167 |
|
|
2017
Q3 | USD 506 k | Comprar |
28,291
+1,531
| +6% | +USD 25.6 k | ﹤0.01% | 956 |
|
|
2017
Q2 | USD 436 k | Vender |
26,760
-1,127
| -4% | -USD 16.2 k | ﹤0.01% | 1005 |
|
|
2017
Q1 | USD 390 k | Vender |
27,887
-7,031
| -20% | -USD 100 k | ﹤0.01% | 1112 |
|
|
2016
Q4 | USD 557 k | Comprar |
34,918
+4,006
| +13% | +USD 64.4 k | 0.01% | 1028 |
|
|
2016
Q3 | USD 514 k | Vender |
30,912
-5,695
| -16% | -USD 76.7 k | 0.01% | 944 |
|
|
2016
Q2 | USD 410 k | Vender |
36,607
-411
| -1% | -USD 3.98 k | 0.01% | 1054 |
|
|
2016
Q1 | USD 309 k | Vender |
37,018
-3,501
| -9% | -USD 28.7 k | ﹤0.01% | 1195 |
|
|
2015
Q4 | USD 377 k | Comprar |
40,519
+4,279
| +12% | +USD 42.7 k | ﹤0.01% | 1181 |
|
|
2015
Q3 | USD 409 k | Vender |
36,240
-2,432
| -6% | -USD 29.7 k | 0.01% | 1001 |
|
|
2015
Q2 | USD 491 k | Vender |
38,672
-2,413
| -6% | -USD 26 k | 0.01% | 1102 |
|
|
2015
Q1 | USD 382 k | Comprar |
41,085
+6,808
| +20% | +USD 76.9 k | ﹤0.01% | 1319 |
|
|
2014
Q4 | USD 491 k | Comprar |
34,277
+3,364
| +11% | +USD 39.8 k | 0.01% | 1205 |
|
|
2014
Q3 | USD 321 k | Vender |
30,913
-6,160
| -17% | -USD 80.7 k | ﹤0.01% | 1674 |
|
|
2014
Q2 | USD 600 k | Vender |
37,073
-22,151
| -37% | -USD 295 k | 0.01% | 1467 |
|
|
2014
Q1 | USD 962 k | Comprar |
59,224
+42,187
| +248% | +USD 600 k | 0.01% | 1341 |
|
|
2013
Q4 | USD 211 k | Vender |
17,037
-15,559
| -48% | -USD 156 k | ﹤0.01% | 1248 |
|
|
2013
Q3 | USD 358 k | Comprar |
32,596
+8,818
| +37% | +USD 94.2 k | 0.01% | 1753 |
|
|
2013
Q2 | USD 192 k | Comprar |
+23,778
| Nuevas | +USD 160 k | ﹤0.01% | 2058 |
|
Otros fondos que tienen VNDA en su cartera
ACM
Posición de ProShare Advisors en VNDA: resumen de T2 2026
ProShare Advisors cerró por completo su posición en Vanda Pharmaceuticals (VNDA) en T2 2026, liquidando una posición de 10,731 acciones por un valor estimado de USD 74.2 k.
ProShare Advisors reportó por primera vez una posición en VNDA en T2 2013 y la mantuvo durante 52 trimestres. La posición alcanzó su máximo de USD 962 k en T1 2014. Al cierre de T2 2026, 172 fondos que sigue Wall St. Rank mantienen una posición en VNDA.
- ProShare Advisors reportó que ya no tenía una posición en Vanda Pharmaceuticals al cierre de T2 2026, después de venderla por completo durante el trimestre.
- ProShare Advisors vendió 10,731 acciones de Vanda Pharmaceuticals en T2 2026, por un valor estimado de USD 74.2 k.
- ProShare Advisors reportó por primera vez una posición en Vanda Pharmaceuticals en T2 2013 y la mantuvo durante 52 trimestres.
- La posición de ProShare Advisors en Vanda Pharmaceuticals alcanzó su máximo de USD 962 k en T1 2014.
- Al cierre de T2 2026, 172 fondos que sigue Wall St. Rank tenían Vanda Pharmaceuticals en cartera.
Según el Informe 13F de ProShare Advisors correspondiente a T2 2026, presentado el 11 ago 2026.